Bionano Genomics (BNGO) Non Operating Income (2017 - 2026)

Bionano Genomics has reported Non Operating Income for 10 years, with the latest figure at $223000.0 in Q1 2026.

• Quarterly Non Operating Income fell 23.1% year-over-year to $223000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 218.56% YoY) and the FY2025 annual result came in at $1.1 million, down 47.12% from the prior year.
• Non Operating Income improved to $223000.0 in Q1 2026 per BNGO's latest filing, from -$5.3 million in the prior quarter.
• Over five years, Non Operating Income peaked at $1.9 million in Q4 2024 and troughed at -$19.0 million in Q4 2023.
• A 5-year average of -$962375.0 and a median of $372000.0 in 2022 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income jumped 1168.97% in 2022, then tumbled 2564.16% in 2023.
• Over 5 years, Non Operating Income stood at $770000.0 in 2022, then sank by 2564.16% to -$19.0 million in 2023, then surged by 110.11% to $1.9 million in 2024, then tumbled by 374.21% to -$5.3 million in 2025, then surged by 104.24% to $223000.0 in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $223000.0, -$5.3 million, and $49000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.